SEKINE Ikuo

Researcher's full information

Articles
  • A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with breast cancer
    Sekine Ikuo
    Int J Clin Oncol/14(2)/pp.112-119, 2009-04
    PubMed
  • Innovator and generic cisplatin formulations: comparison of renal toxicity
    Sekine Ikuo
    Cancer Sci/102(1)/pp.162-165, 2010-11
    PubMed
  • Phase I study of concurrent high-dose three-dimensional conformal radiotherapy with chemotherapy using cisplatin and vinorelbine for unresectable stage III non-small cell lung cancer
    Sekine Ikuo
    Int J Radiat Oncol Biol Phys/82(2)/pp.953-959, 2011-04
    PubMed
  • Risk factors of chemotherapy-induced nausea and vomiting: index for personalized antiemetic prophylaxis
    Sekine Ikuo
    Cancer Sci/104(6)/pp.711-717, 2013-04
    PubMed
  • Clinical classification of targeted agents used for anticancer treatment.
    Sekine Ikuo
    Tohoku J Exp Med/230(1)/pp.1-5, 2013-04
    PubMed
  • A randomized phase III study of single-agent amrubicin vs. carboplatin/etoposide in elderly patients with extensive-disease small-cell lung cancer
    Sekine Ikuo
    Clin Lung Cancer/15(2)/pp.96-102, 2013-11
    PubMed